 PRINCETON, N.J., Nov. 02, 2021 GLOBE NEWSWIRE -- Oyster Point Pharma, Inc. Nasdaq: OYST, a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases, today announced multiple scientific presentations at the American Academy of Optometry AAOpt Annual Meeting 2021 being held in Boston, MA November 3 - 6, 2021. 